Press Release
-
Renewable ethylene update
.
Hello blog followers. I was unable to blog until now due to very tight schedules and deadlines after my two-week holiday in September. We published our October Bio-Materials report last Tuesday, and I just want to share some interesting news…
-
Bioplastic, Company initiatives, Investments, Partnership, Press Release, Products, R&D, Tecnon OrbiChemBio-BDO and Succinic Acid Updates
.
My schedule this October is so tight, but I need to squeeze in these two announcements because it’s rare these days to receive information on bio-based succinic acid and bio-based 1,4-butanediol (BDO). This brief news a month ago about TechnipEnergies…
-
Give bio-based products in the EU a chance
.
The European Bioplastics organisation gave me a heads-up on this. interesting development about the EU’s Product Environmental Footprint (PEF) method, which can help companies calculate their environmental performance based on reliable, verifiable and comparable information, and for other actors (public…
-
UPM gears up for bio-MEG commercialization
.
UPM Biochemicals is gearing up for its incoming wood-based glycols production in Leuna, Germany, which is expected to be operational by the end of 2023 and ramping up to its full 220 ktpa biorefinery capacity by 2024. The main products…
-
ABT launches new bio-ECH brand EPINITY™
.
This is an excerpt from this month’s bio-based epichlorohydrin (ECH) coverage on Tecnon OrbiChem’s Bio-Materials report. Advanced Biochemical Thailand (ABT) launched its new product brand EPINITY™ for its glycerine-based ECH to position the product’s unique value proposition and sustainability benefits….
-
LG Chem and ADM Launch PLA and Lactic Acid JVs
.
This collaboration between South Korea-based LG Chem and US agribusiness company Archer Daniels Midland (ADM) on a potential production of lactic acid and polylactic acid (PLA) in the USA has been announced before, but this time, the press release that…
-
Ginkgo on a buying spree, acquires Zymergen
.
Synthetic biology company Ginkgo Bioworks announced today that it plans to acquire Zymergen in an all-stock transaction valued at $300 million in market capitalisation. Zymergen stockholders will receive a fixed exchange ratio of 0.9179 Ginkgo shares for each Zymergen share,…